Close Menu

NEW YORK (360Dx) – VANC Pharmaceutical today announced a shared purchase agreement to acquire all outstanding common shares of HealthTab, a point-of-care platform for Canadian pharmacists for cholesterol, triglyceride, and other testing and monitoring.

Under the terms of the deal, VANC will pay C$200,000 (US$157,471) in cash to HealthTab's vendors, including C$100,000 at closing. The balance will be subsequently paid in six equal installments.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.